Prothena | PRTA - EPS Earnings Per Share


Prothena reported $0.6 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
0.10 -0.68 Oct/29
-0.36 0.32 -2.34 Aug/06
FY2027Q1 Mar/2026 0.60 -0.35 -1.12 May/07




Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
ALKERMES USD 0 0.4 Jun/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Exelixis USD 0.91 0.04 Jun/2026
Immunic USD -0.1 0.03 Dec/2025
Incyte USD 3.09 1.28 Jun/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
MacroGenics USD -0.58 0.36 Mar/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Prothena USD 0.6 1.06 Mar/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026